Yahoo Web Search

Search results

    • ASCO24: An early look at cancer drug study results

      ASCO24: An early look at cancer drug study results

      BioPharma Dive via Yahoo Finance· 2 days ago

      Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...

    • This Unpopular Dividend Stock Is a Buy

      This Unpopular Dividend Stock Is a Buy

      Motley Fool via Yahoo Finance· 2 days ago

      BMS is facing one of the steepest patent cliffs in the industry come 2028 when cancer medication Opdivo and blood thinner Eliquis could both face generic...